Results 251 to 260 of about 18,379 (288)
Some of the next articles are maybe not open access.

Treosulfan‐based reduced toxicity hematopoietic stem cell transplantation in X‐linked agammaglobulinemia: A cost‐effective alternative to long‐term immunoglobulin replacement in developing countries

Pediatric Transplantation, 2019
X‐linked agammaglobulinemia (XLA) is a primary antibody disorder due to a mutation in the Bruton tyrosine kinase gene that requires lifelong immunoglobulin replacement resulting in a significant economic burden and treatment abandonment.
V. Vellaichamy Swaminathan   +7 more
semanticscholar   +1 more source

Familial Agammaglobulinemia

International Archives of Allergy and Immunology, 1961
M, DIAMANT, P, KALLOS, G, RUBENSOHN
openaire   +2 more sources

Current Spectrum of Infections in Patients with X-Linked Agammaglobulinemia

Journal of Clinical Immunology, 2021
O. Paccoud   +12 more
semanticscholar   +1 more source

ADULT AGAMMAGLOBULINEMIA

Archives of Internal Medicine, 1955
R L, WALL, S, SASLAW
openaire   +2 more sources

TCF3 Dominant Negative Variant Causes an Early Block in B-Lymphopoiesis and Agammaglobulinemia

Journal of Clinical Immunology, 2021
Ebtehal Al Sheikh   +4 more
semanticscholar   +1 more source

Agammaglobulinemia

Medical Clinics of North America, 1956
openaire   +2 more sources

Helicobacter cinaedi-Associated Refractory Cellulitis in Patients with X-Linked Agammaglobulinemia

Journal of Clinical Immunology, 2020
Kento Inoue   +6 more
semanticscholar   +1 more source

Agammaglobulinemia

Scientific American, 1957
David Gitlin, Charles A. Janeway
openaire   +2 more sources

Expression of the Gene Defect in X-Linked Agammaglobulinemia

New England Journal of Medicine, 1986
Jack W Singer
exaly  

Home - About - Disclaimer - Privacy